CME To Stay Focused On OTC
Craig Donohue, ceo of CME Group, said his firm will continue to focus on “doing what we do well,” namely in futures and over-the-counter derivatives.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
